Significantly, a negative effect of ID2 overexpression on CR rate was observed among whole-cohort AML, non-M3-AML and CN-AML patients, which indicated that ID2 overexpression was associated with poor induction chemotherapy response, and ID2 expression might play a crucial role in affecting leukemia cell chemosensitivity in AML. This evidence concerns the gene ID2 and leukemia.